ANI Pharmaceuticals ANIP Intangible assets — net
Intangible assets — net at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's intangible assets — net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's intangible assets — net?
- ANI Pharmaceuticals (ANIP) reported intangible assets — net of $467.16M in Q1 2026.
- How has ANI Pharmaceuticals's intangible assets — net changed year-over-year?
- ANI Pharmaceuticals's intangible assets — net decreased by 10.6% year-over-year, from $522.7M to $467.16M.
- What is the long-term trend for ANI Pharmaceuticals's intangible assets — net?
- Over 2 years (2023 to 2025), ANI Pharmaceuticals's intangible assets — net has grown at a 59.2% compound annual growth rate (CAGR), from $189.21M to $479.53M.